Publications

5808 Results

A phase II trial of sorafenib in patients with relapsing and resistant multiple myeloma (MM) previously treated with bortezomib (S0434)

Authors
G Srkalovic;M Hussein;V Bolejack;A Hoering;JA Zonder;B Barlogie
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #e19517
Year
2009
Research Committee(s)
Myeloma
Study Number(s)
S0434

SWOG S0509: A phase II study of novel oral anti-angiogenic agent AZD2171 (NSC-732208) in malignant pleural mesothelioma

Authors
LL Garland;M Redman;A Wozniak;AS Tsao;S Gadgeel;C Vershraegen;M Da Silva;K Chansky;DR Gandara
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #7511
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0509

Phase I evaluation of lapatinib and everolimus in patients (pts) with advanced malignancies: Southwest Oncology Group trial (S0528)

Authors
CJ Hoban;A Hoering;TW Synold;V Chung;DR Gandara;AF Schott;L Kingsbury;D Lew;P LoRusso;SM Gadgeel
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. 3553 (poster)
Year
2009
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S0528

Chemoradiation of resected gastric cancer: a 10 year followup of INT0116 (SWOG 9008)

Authors
J Macdonald;J Benedetti;SR Smalley;D Haller;S Hundahl;J Jessup;J Ajani;LL Gunderson;B Goldman;JA Martenson
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #4515
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Southwest Oncology Group S9921: prolonged event free survival in high risk prostate cancer (PC) patients receiving adjuvant androgen deprivation.

Authors
LM Glode;CM Tangen;MHA Hussain;DP Wood;GP Swanson;N Dawson;N Balzer-Haas;DI Quinn;ED Crawford;IM Thompson
Journal / Conference
Journal of Clinical Oncology 27:15s, abst.#5009
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Communicating the early end of intervention to participants in a large ongoing study

Authors
J Hartlline;E Cook;J Harris-Talley;K Weaver
Journal / Conference
American Society for Preventive Oncology, poster presentation;
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

International prognostic scoring system for Waldenstrom's macroglobulinemia [PMID19196866]

Authors
P Morel;A Duhamel;P Gobbi;M Dimopoulos;MV Dhodapkar;J McCoy;JJ Crowley;E Ocio;R Garcia-Sanz;S Treon;V Leblond;R Kyle;B Barlogie;G Merlini
Journal / Conference
Blood 113(18):4163-4170
Year
2009
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9003

Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study [PMC2837883;PMID20130422]

Authors
AD Tiersten;J Moon;HO Smith;SP Wilczynski;WR Robinson;M Markman;JP Fruehauf;DS Alberts
Journal / Conference
Oncology 77(6):395-399
Year
2009
Research Committee(s)
Gynecologic
Study Number(s)
S0009

Nitric oxide synthase (N0S3) variants and breast cancer survival in a cooperative group trial (SWOG S8897) [PMC2745926; PMID19671875]

Authors
J-Y Choi;WE Barlow;KS Albain;C-C Hong;JG Blanco;RB Livingston;W Davis;JM Rae;I-T Yeh;LF Hutchins;PM Ravdin;S Martino;AP Lyss;CK Osborne;M Abeloff;DF Hayes;CB Ambrosone
Journal / Conference
Clinical Cancer Research, 15(16):5258-66, 2009;
Year
2009
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Southwest Oncology Group trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer [PMC2703693; PMID19464730]

Authors
HO Smith;J Moon;SP Wilczynski;AD Tiersten;EV Hannigan;WR Robinson;SE Rivkin;GL Anderson;PY Liu;M Markman
Journal / Conference
Gyecologic Oncology 114(2):206-209
Year
2009
Research Committee(s)
Gynecologic
Study Number(s)
S9912